Enzymes As Drug Targets

?
Enzymes
Biological catalysts, central to all aspects of cellular function. Largest group of targets in the body 47%. Specialised binding sites that have certain substrates.
1 of 22
V max
That maximum rate at which an enzyme can carry out a reaction
2 of 22
Km
Substrate concentration at which the enzyme will work at 1/2 V max.
3 of 22
Competitive Inhibitor
Block the enzyme's active site.
4 of 22
Non-competitive Inhibitor
Bind to the enzyme somewhere other than the active site of the enzyme (allosteric site)
5 of 22
DD Transpeptidases
DD Transpeptidases is a bacterial enzyme that catalyzes the transfer of the R-L-aca-D-alanyl moiety of R-L-aca-D-alanyl-D-alanine carbonyl donors to the γ-OH of their active-site serine and from this to a final acceptor.
6 of 22
DD Transpeptidases Action
• Carries out crosslinking of peptidoglycan wall subunits for bacteria • Also known as penicillin binding protein (PBP) • Beta lactam antibiotics bind to and irreversibly inhibit DD Transpeptidase.
7 of 22
Protein Chemical Warfare
Bacteria counter the impact of beta lactam drugs by producing an enzymatic defence system. Some forms of antibiotic resistance.
8 of 22
HIV Protease
A retroviral aspartyl protease, enzyme involved with peptide bond hydrolysis in retroviruses, used in the life-cycle of HIV. Cleaves viral virion proteins required to form the active virus.
9 of 22
Atazanavir/ Reyataz
Antiretroviral medication used to treat and prevent HIV/AIDS after a needlestick injury. Acts an inhibitor to HIV enzyme, protease in the HIV genome to suppress any infection.
10 of 22
Targeting Human Enzymes
Changes in protein sequences caused by mutations leads to a host of human diseases. Drugs can be used to correct these changes.
11 of 22
Angiontensis Converting Enzyme (ACE)
Renin-angiotensin system which controls blood pressure by regulating the volume of fluids. Converts the hormone angiotensin I to the active vasoconstrictor angiotensin II
12 of 22
Ramipril
Inhibits ACE activity, decreases the production of angiotensin II. Increases risk of stroke, as it binds as a competitive inhibitor.
13 of 22
Prostaglandin-endoperoxide synthase/ Cyclooxygenase
The enzyme that forms prostanoids.
14 of 22
Inhibition of COX
Provide relief from the symptoms of inflammation and pain. Reduce the synthesis of prostaglandins.
15 of 22
Prostaglandins
Active lipid compounds called eicoanoids having diverse hormone life effects in animals. Derived enzymatically from fatty acid arachidonic acid.
16 of 22
Substantial concentrations of ibuprofen
Attained in synovial fluid for nonsteroidal anti-inflammatory drugs. . Ibuprofen is eliminated following biotransformation to glucuronide conjugate metabolites that are excreted in urine.
17 of 22
Protein Kinases
Integral part of signalling cascades within the cell. Hydrolyse ATP through covenant modification to modify protein function.
18 of 22
Imatinib
Type of biological therapy called tyrosine kinase inhibition (TKI). Acts as chemical messengers.
19 of 22
Bcr/Abl
Kinase domain that is hyperactive in chronic myelogenous leukaemia (CML)
20 of 22
Allosteric Modulation
Ligands able to directly active a receptor by binding to an allosteric agonist. Can alter the overall protein shape.
21 of 22
Allosteric Regulation
The regulation of an enzyme by binding an effector molecule at a site other than the enzyme's active site.
22 of 22

Other cards in this set

Card 2

Front

That maximum rate at which an enzyme can carry out a reaction

Back

V max

Card 3

Front

Substrate concentration at which the enzyme will work at 1/2 V max.

Back

Preview of the back of card 3

Card 4

Front

Block the enzyme's active site.

Back

Preview of the back of card 4

Card 5

Front

Bind to the enzyme somewhere other than the active site of the enzyme (allosteric site)

Back

Preview of the back of card 5
View more cards

Comments

No comments have yet been made

Similar Pharmacy resources:

See all Pharmacy resources »See all Pharmacology and Toxicology resources »